Literature DB >> 16251404

Opiate abuse and viral replication in hepatitis C.

Kevin Moore1, Geoff Dusheiko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16251404      PMCID： PMC1603777          DOI： 10.1016/S0002-9440(10)61207-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  15 in total

1.  A centrally-mediated effect of morphine to diminish hepatocellular glutathione.

Authors:  S M Roberts; N P Skoulis; R C James
Journal:  Biochem Pharmacol       Date:  1987-09-15       Impact factor: 5.858

2.  Morphine withdrawal enhances hepatitis C virus replicon expression.

Authors:  Chuan-Qing Wang; Yuan Li; Steven D Douglas; Xu Wang; David S Metzger; Ting Zhang; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

3.  Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages.

Authors:  B M Sharp; W F Keane; H J Suh; G Gekker; D Tsukayama; P K Peterson
Journal:  Endocrinology       Date:  1985-08       Impact factor: 4.736

4.  Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity.

Authors:  P K Peterson; B Sharp; G Gekker; C Brummitt; W F Keane
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

5.  Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells.

Authors:  P K Peterson; B Sharp; G Gekker; C Brummitt; W F Keane
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

6.  The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor.

Authors:  Jinghua Wang; Richard Charboneau; Sudha Balasubramanian; Roderick A Barke; Horace H Loh; Sabita Roy
Journal:  J Leukoc Biol       Date:  2002-05       Impact factor: 4.962

7.  Morphine enhances HIV infection of neonatal macrophages.

Authors:  Yuan Li; Jeffrey D Merrill; Kathy Mooney; Li Song; Xu Wang; Chang-Jiang Guo; Rashmin C Savani; David S Metzger; Steven D Douglas; Wen-Zhe Ho
Journal:  Pediatr Res       Date:  2003-05-07       Impact factor: 3.756

8.  Opioid receptor blockade reduces Fas-induced hepatitis in mice.

Authors:  Martial Jaume; Sébastien Jacquet; Pierre Cavaillès; Gaëtane Macé; Lionel Stephan; Catherine Blanpied; Cécile Demur; Pierre Brousset; Gilles Dietrich
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

9.  Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis?

Authors:  Seyed Ali Gaskari; Ali Reza Mani; Shahram Ejtemaei-Mehr; Khodadad Namiranian; Houman Homayoun; Hossein Ahmadi; Ahmad Reza Dehpour
Journal:  Fundam Clin Pharmacol       Date:  2002-08       Impact factor: 2.748

10.  Morphine enhances hepatitis C virus (HCV) replicon expression.

Authors:  Yuan Li; Ting Zhang; Steven D Douglas; Jian-Ping Lai; Wei-Dong Xiao; David E Pleasure; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307
View more
  4 in total

1.  Impact of substance abuse on treatment adherence.

Authors:  Adegboyega Oyemade
Journal:  Psychiatry (Edgmont)       Date:  2008-11

Review 2.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

3.  micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.

Authors:  Dania Chakass; David Philippe; Edmone Erdual; Sébastien Dharancy; Mathilde Malapel; Caroline Dubuquoy; Xavier Thuru; Jerome Gay; Claire Gaveriaux-Ruff; Pierre Dubus; Philippe Mathurin; Brigitte L Kieffer; Pierre Desreumaux; Mathias Chamaillard
Journal:  Gut       Date:  2007-02-13       Impact factor: 23.059

4.  Characteristics of opioid prescribing to outpatients with chronic liver diseases: A call for action.

Authors:  Olufunso M Agbalajobi; Theresa Gmelin; Andrew M Moon; Wheytnie Alexandre; Grace Zhang; Walid F Gellad; Naudia Jonassaint; Shari S Rogal
Journal:  PLoS One       Date:  2021-12-17       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.